Chart calendar Johnson & Johnson

95739c96e52404f433137eb2ff.uaB1KQ37ByGBBvitilkjHEiqTvfWqRvlDE0pJbrD3pA.1_MdfFzMUgzLP6qYwWFtfgX6L5C80CufXz1MVorz7NGI7zZYWKFAYM1zvQ~090a4526f70aa8871af053e056833d4a

Upcoming events on Johnson & Johnson

2025-01-21 Q4 2024 Earnings Release Pre-market
2025-01-22 08:30 am Q4 2024 Earnings Call
2025-04-14 Q1 2025 Earnings Release Pre-market
2025-04-15 08:30 am Q1 2025 Earnings Call
2025-07-21 Q2 2025 Earnings Release (Projected)
2025-10-20 Q3 2025 Earnings Release (Projected)
2026-01-26 Q4 2025 Earnings Release (Projected)
2026-04-20 Q1 2026 Earnings Release (Projected)

Past events on Johnson & Johnson

2024-11-25 Détachement de
2024-11-18 02:00 pm American College of Rheumatology Meeting - scRNAseq SjD Predictors
2024-11-18 10:55 am Stifel Healthcare Conference
2024-11-18 10:30 am American College of Rheumatology Meeting - Poster No:2047
2024-11-18 10:30 am American College of Rheumatology Meeting - Poster No:2357
2024-11-18 10:30 am American College of Rheumatology Meeting - Poster No:2353
2024-11-18 10:30 am American College of Rheumatology Meeting - Poster No:1904
2024-11-18 10:30 am American College of Rheumatology Meeting - Poster No:2316
2024-11-18 10:30 am American College of Rheumatology Meeting - Poster No:2342
2024-11-18 10:30 am American College of Rheumatology Meeting - Poster No:1912
2024-11-18 10:30 am American College of Rheumatology Meeting - Poster No:2001
2024-11-18 10:30 am American College of Rheumatology Meeting - Poster No:2416
2024-11-18 10:30 am American College of Rheumatology Meeting - Poster No:1976
2024-11-18 10:30 am American College of Rheumatology Meeting - Poster No:1988
2024-11-18 10:30 am American College of Rheumatology Meeting - Poster No:2294
2024-11-18 09:00 am American College of Rheumatology Meeting - Poster No:2527
2024-11-17 03:00 pm American College of Rheumatology Meeting - BRASS 3 RA Remission
2024-11-17 10:30 am American College of Rheumatology Meeting - Poster No:1496
2024-11-17 10:30 am American College of Rheumatology Meeting - Poster No:1132
2024-11-17 10:30 am American College of Rheumatology Meeting - Poster No:1474

Past dividends on Johnson & Johnson

2024-11-25 Quarterly 1.24 USD
2024-08-26 Quarterly 1.24 USD
2024-05-19 Quarterly 1.24 USD
2024-02-15 Quarterly 1.19 USD
2023-11-19 Quarterly 1.19 USD
2023-08-24 Quarterly 1.19 USD
2023-05-21 Quarterly 1.19 USD
2023-02-16 Quarterly 1.13 USD
2022-11-20 Quarterly 1.13 USD
2022-08-21 Quarterly 1.13 USD
2022-05-22 Quarterly 1.13 USD
2022-02-17 Quarterly 1.06 USD
2021-11-21 Quarterly 1.06 USD
2021-08-22 Quarterly 1.06 USD
2021-05-23 Quarterly 1.06 USD
2021-02-21 Quarterly 1.01 USD
2020-11-22 Quarterly 1.01 USD
2020-08-23 Quarterly 1.01 USD
2020-05-21 Quarterly 1.01 USD
2020-02-23 Quarterly 0.95 USD

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Million USD
Released
Forecast
Spread
93 775
94 304
-0.56%
94 943
95 017
-0.08%
85 159
84 764
0.47%

88 784


91 329


94 695

EBITDA
Million USD
Released
Forecast
Spread
36 634
33 066
10.79%
32 630
32 564
0.2%
30 414
31 998
-4.95%

30 468


32 898


35 170

EBIT
Million USD
Released
Forecast
Spread
29 244
30 088
-2.8%
29 965
29 608
1.21%
27 460
27 881
-1.51%

26 974


29 447


31 128

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
22 776
24 759
-8.01%
21 725
25 756
-15.65%
15 062
20 454
-26.36%

22 891


24 304


25 790

Net income
Million USD
Released
Forecast
Spread
20 878
22 542
-7.38%
17 941
20 668
-13.19%
35 153
19 696
78.48%

17 499


20 759


22 291

EPS
USD
Released
Forecast
Spread
7,81
8,42
-7.29%
6,73
7,95
-15.29%
13,7
8,44
62.56%

6,86


8,74


9,41

Announcement Date25/01/2224/01/2323/01/24-

Quarterly results

Fiscal PeriodSeptember 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3
Net sales
Million USD
Released
Forecast
Spread
24 746
23 599
4.86%
25 530
24 668
3.49%
21 351
21 049
1.43%
21 395
21 017
1.8%
21 383
21 386
-0.01%
22 447
22 337
0.49%
22 471
22 171
1.35%

22 450


22 042


22 933


23 193


23 238


23 269


24 312


24 541

EBITDA
Million USD
Released
Forecast
Spread
8 880
8 484
4.66%
8 912
8 671
2.78%
8 071
7 683
5.04%
6 333
6 788
-6.7%
7 973
7 747
2.92%
8 388
8 129
3.18%
7 164
7 063
1.43%

6 250


8 425


8 420


8 273


7 799


8 689


9 118


7 902

EBIT
Million USD
Released
Forecast
Spread
8 204
7 411
10.7%
8 189
7 753
5.62%
7 374
6 967
5.83%
5 638
6 015
-6.27%
7 236
7 203
0.46%
7 712
7 433
3.76%
6 489
6 085
6.63%

5 469


7 393


7 567


7 501


6 845


7 835


8 263


7 045

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-737
6 708
-110.99%
6 762
7 242
-6.63%
5 217
7 202
-27.56%
4 826
5 043
-4.3%
6 440
6 329
1.75%
5 748
6 910
-16.82%
3 338
4 923
-32.2%

4 971






















Net income
Million USD
Released
Forecast
Spread
-68,0
5 573
-101.22%
5 144
5 866
-12.3%
26 028


4 049
3 880
4.34%
5 354
5 293
1.15%
4 686
5 093
-8%
2 694
4 083
-34.02%

4 287


6 529


6 797


5 727


6 195


6 754


7 114


6 119

EPS
USD
Released
Forecast
Spread
-0,03
2,10
-101.43%
1,96
1,89
3.45%
10,2
2,17
370.51%
1,67
1,68
-0.81%
2,20
2,21
-0.57%
1,93
2,09
-7.72%
1,11
1,69
-34.13%

1,70


2,47


2,56


2,35


2,38


2,83


2,98


2,56

Announcement Date18/04/2320/07/2317/10/2323/01/2416/04/2417/07/2415/10/24--------

Quarterly revenue - Rate of surprise

quality-estimates-chart JOHNSON-JOHNSON

Net sales - Rate of surprise

quality-estimates-chart JOHNSON-JOHNSON

Annual profits - Rate of surprise

quality-estimates-chart JOHNSON-JOHNSON
  1. Stock Market
  2. Equities
  3. JNJ Stock
  4. Calendar Johnson & Johnson